About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

The author of The Forever Strong Playbook stops by The Huddle podcast to break down "musclespan" and discuss those trendy ...

A post‑meal compound found in python blood curbed appetite in lab mice, hinting at future weight loss therapies.

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.

Indianapolis-based Eli Lilly just logged another big win in the metabolic medicine race, reporting that its experimental triple-agonist drug retatrutide cleared a late-stage trial in people with type ...

Lancashire's director of public health says there needs to a wider conversation about healthy eating.

Fans are losing it after John Goodman flaunted his dramatic weight loss at the SXSW conference. Read more at SheFinds.com.

By Rishika Sadam HYDERABAD, March 19 (Reuters) - India's market for diabetes and weight-loss drugs is set for a shake-up as ...

Alcohol and Weight Loss Medications This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA It’s normal to have lots ...

With the obesity numbers for Eli Lilly’s retatrutide already stacking up nicely, the company has rounded out its pitch for the triple agonist with top-line data on its ability to lower blood sugar ...